Network Medicine and Big Data Day 20th of October 2021
The 20th October 2021 KI NMA will host a full day with lectures and panel debates around the topic of Network Medicine and Big Data.
The morning session will focus introductory seminars about network medicine and the afternoon session will go more in depth with lectures followed by panel debates.
Morning session ONLINE
Time: 09:00 - 12:00
Location: Online (link will be sent out after registration, max 500 participants)
09:10 Introduction on basic concepts
Speaker: Lucia Altucci, MD, PhD, Professor of General Pathology at Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
10:00 Integrated Network Approaches for Chemical Safety Assessment and Drug Design
Speaker:Dario Greco, PhD, Professor at Faculty of Medicine and Health Technology, BioMediTech Institute, Tampere University & Institute of Biotechnology, Helsinki Institute for Life Science (HiLife), University of Helsinki. Director at Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE).
10:50-11:00 short break
11:00 What is needed to work in a multi-disciplinary team?
Speaker: Tom Maes, Head of PS Innovation Management, Bayer AG
11:50-12:00 Concluding remarks and information about the afternoon session
Location: Eva & George Klein, BioMedicum, floor 3, Solna vägen 9. Will also be streamed online. Registration needed.
14:00 Welcome and introduction
14:10 Potential of network medicine and big data – future strategies
Speaker: Jean-Luc Balligand, MD PhD, Professor of Medicine and Pharmacology, Pole of Pharmacology and Therapeutics (FATH), Institute for Clinical and Experimental Research (IREC), UCLouvain, Brussels, Belgium.
Moderator: Nanna Fyhrquist, IMM
Magnus Boman, Professor in Intelligent Software Systems. Docent (habilitation) at Stockholm University. Computational epidemiologist, specializing in mental health and epigenetics. Affiliated with KI/LIME and on the Karolinska Precision Medicine Task Force. Associate editor of Eurosurveillance journal. Affiliated with KCL and UCL in London, and a fellow of the Royal Society of Medicine.
Ingemar Ernberg, Professor of Tumor Biology at the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet.
15:15 - 15:45 Short break (coffee will be served)
15:45 Implementation in healthcare
Speaker: Richard Rosenquist Brandell, Professor of Clinical Genetics at the Department of Molecular Medicine and Surgery, Karolinska Institutet and Senior Physician in Clinical Genetics at Karolinska University Hospital, Stockholm, Sweden
Moderator: Volker Lauschke, FyFa
Richard Rosenquist Brandell
Paolo Parini, LabMed, MedH
16:50 – 17:00 Concluding remarks
The schedule below is being updated contiunously.